Do Patients With Lennox-Gastaut Syndrome Respond Differently to Diazepam Nasal Spray (Valtoco®) Than Other Patients with Pediatric Encephalopathies? Final Safety and Effectiveness Results From a Phase 3, Long-Term Open-Label, Repeat-Dose Safety Study

被引：0
|
作者：
Tarquinio, D.
Wheless, J.
Segal, E.
Misra, S.
Rabinowicz, A.
Carrazana, E.
机构：
来源：
ANNALS OF NEUROLOGY | 2022年 / 92卷
关键词：
Epilepsy/Sleep;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
43
引用
收藏
页码：S73 / S75
页数：3
相关论文
共 50 条
  • [1] Safety of Valtoco® (Diazepam Nasal Spray) in Children and Adolescents With Epilepsy: Final Subgroup Results From a Phase 3, Long-Term Open-Label, Repeat-Dose Safety Study
    Tarquinio, D.
    Dlugos, D.
    Wheless, J.
    Desai, J.
    Boro, A.
    Carrazana, E.
    Rabinowicz, A.
    ANNALS OF NEUROLOGY, 2021, 90 : S128 - S128
  • [2] Safety of diazepam nasal spray (Valtoco®) in patients with epilepsy: Final results from a phase 3, open-label, 12-month, repeat-dose safety study
    Wheless, James
    Sperling, Michael
    Liow, Kore
    Segal, Eric
    Hogan, Robert
    Tarquinio, Daniel
    Mauney, Weldon
    Desai, Jay
    Dlugos, Dennis
    Biton, Victor
    Cascino, Gregory
    Carrazana, Enrique
    Rabinowicz, Adrian
    EPILEPSIA, 2021, 62 : 146 - 147
  • [3] Final results from a Phase 3, long-term, open-label, repeat-dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy
    Wheless, James W.
    Miller, Ian
    Hogan, R. Edward
    Dlugos, Dennis
    Biton, Victor
    Cascino, Gregory D.
    Sperling, Michael R.
    Liow, Kore
    Vazquez, Blanca
    Segal, Eric B.
    Tarquinio, Daniel
    Mauney, Weldon
    Desai, Jay
    Rabinowicz, Adrian L.
    Carrazana, Enrique
    EPILEPSIA, 2021, 62 (10) : 2485 - 2495
  • [4] Lack of observed tolerance to diazepam nasal spray (Valtoco®) after long-term rescue therapy in patients with epilepsy: Interim results from a phase 3, open-label, repeat-dose safety study
    Cascino, Gregory D.
    Tarquinio, Daniel
    Wheless, James W.
    Hogan, R. Edward
    Sperling, Michael R.
    Liow, Kore
    Desai, Jay
    Davis, Charles
    Rabinowicz, Adrian L.
    Carrazana, Enrique
    EPILEPSY & BEHAVIOR, 2021, 120
  • [5] Safety Profile of Valtoco® (diazepam nasal spray) in Patients With Epilepsy: Final Results From a Phase 3, Open-Label, 12-Month Repeat Dose Safety Study
    Wheless, James
    Sperling, Michael
    Liow, Kore
    Segal, Eric
    Miller, Ian
    Hogan, R. Edward
    Tarquinio, Daniel
    Desai, Jay
    Dlugos, Dennis
    Biton, Victor
    Cascino, Gregory
    Carrazana, Enrique
    Rabinowicz, Adrian L.
    NEUROLOGY, 2021, 96 (15)
  • [6] Consistent safety and tolerability of Valtoco(R) (diazepam nasal spray) in relationship to usage frequency in patients with seizure clusters: Interim results from a phase 3, long-term, open-label, repeat-dose safety study
    Miller, Ian
    Wheless, James W.
    Hogan, Robert E.
    Dlugos, Dennis
    Biton, Victor
    Cascino, Gregory D.
    Sperling, Michael R.
    Liow, Kore
    Vazquez, Blanca
    Segal, Eric B.
    Tarquinio, Daniel
    Mauney, Weldon
    Desai, Jay
    Rabinowicz, Adrian L.
    Carrazana, Enrique
    EPILEPSIA OPEN, 2021, 6 (03) : 504 - 512
  • [7] Time to Second Doses in Children and Adolescents With Epilepsy Treated With Valtoco® (Diazepam Nasal Spray): Final Subgroup Results From a Phase 3, Open-Label, Repeat-Dose Safety Study
    Tarquinio, D.
    Dlugos, D.
    Wheless, J.
    Desai, J.
    Boro, A.
    Rabinowicz, A.
    Carrazana, E.
    ANNALS OF NEUROLOGY, 2021, 90 : S124 - S124
  • [8] Safety of Diazepam Nasal Spray in Pediatric Patients With Developmental Epileptic Encephalopathies: Results From a Long-term Phase 3 Safety Study
    Tarquinio, Daniel
    Wheless, James W.
    Segal, Eric B.
    Misra, Sunita N.
    Rabinowicz, Adrian L.
    Carrazana, Enrique
    JOURNAL OF CHILD NEUROLOGY, 2023, : 389 - 393
  • [9] EXPLORING SERIOUS ADVERSE EVENTS ASSOCIATED WITH HOSPITALIZATIONS IN A LONG-TERM, PHASE 3, OPEN-LABEL, REPEAT-DOSE, SAFETY STUDY OF DIAZEPAM NASAL SPRAY FOR PATIENTS WITH EPILEPSY
    Wheless, J.
    Sperling, M.
    Hogan, R. E.
    Tarquinio, D.
    Dlugos, D.
    Fountain, N.
    Carrazana, E.
    Rabinowicz, A. L.
    VALUE IN HEALTH, 2021, 24 : S159 - S159
  • [10] Long-term safety and efficacy of clobazam for Lennox-Gastaut syndrome: Interim results of an open-label extension study
    Ng, Yu-Tze
    Conry, Joan
    Paolicchi, Juliann
    Kernitsky, Lydia
    Mitchell, Wendy
    Drummond, Rebecca
    Isojarvi, Jouko
    Lee, Deborah
    Owen, Randall
    EPILEPSY & BEHAVIOR, 2012, 25 (04) : 687 - 694
12345